Predictive performance of different bleeding risk scores in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention

References

• Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 2009;30(9):1038–1045. doi:10.1093/eurheartj/ehn579.
   PubMed Web of Science ®Google Scholar
• Kralev S, Schneider K, Lang S, Süselbeck T, Borggrefe M. Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography. PLoS One 2011;6(9):e24964. doi:10.1371/journal.pone.0024964.
   PubMed Web of Science ®Google Scholar
• Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, Cobbe S, Breithardt G, Le Heuzey JY, Prins MH, et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on atrial fibrillation. Eur Heart J 2005;26(22):2422–2434. doi:10.1093/eurheartj/ehi505.
   PubMed Web of Science ®Google Scholar
• Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Juni P, Kastrati A, Kolh P, Mauri L, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018;39(3):213–260. doi:10.1093/eurheartj/ehx419.
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2021;42(5):373–498. doi:10.1093/eurheartj/ehaa612.
   PubMed Web of Science ®Google Scholar
• Lip GYH, Collet JP, Haude M, Byrne R, Chung EH, Fauchier L, Halvorsen S, Lau D, Lopez-Cabanillas N, Lettino M, et al. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace 2019;21(2):192–193. doi:10.1093/europace/euy174.
   PubMed Web of Science ®Google Scholar
• Kumbhani DJ, Cannon CP, Beavers CJ, Bhatt DL, Cuker A, Gluckman TJ, Marine JE, Mehran R, Messe SR, Patel NS, et al. 2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention or with atherosclerotic cardiovascular disease: a report of the American College of Cardiology solution set oversight committee. J Am Coll Cardiol 2021;77(5):629–658. doi:10.1016/j.jacc.2020.09.011.
   PubMed Web of Science ®Google Scholar
• Chinese Society of Cardiology of Chinese Medical Association; Editorial Board of Chinese Journal of Cardiology. Antithrombotic management of patients with atrial fibrillation and coronary artery disease: expert consensus document of Chinese Society of Cardiology. Zhonghua Xin Xue Guan Bing Za Zhi 2020;48(7):552–564. doi:10.3760/cma.j.cn112148-20200328-00257.
   PubMedGoogle Scholar
• Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010;138(5):1093–1100. doi:10.1378/chest.10-0134.
   PubMed Web of Science ®Google Scholar
• Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study. J Am Coll Cardiol 2011;58(4):395–401. doi:10.1016/j.jacc.2011.03.031.
   PubMed Web of Science ®Google Scholar
• O’Brien EC, Simon DN, Thomas LE, Hylek EM, Gersh BJ, Ansell JE, Kowey PR, Mahaffey KW, Chang P, Fonarow GC, et al. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. Eur Heart J 2015;36(46):3258–3264. doi:10.1093/eurheartj/ehv476.
   PubMed Web of Science ®Google Scholar
• Ducrocq G, Wallace JS, Baron G, Ravaud P, Alberts MJ, Wilson PW, Ohman EM, Brennan DM, D’Agostino RB, Bhatt DL, et al. Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis. Eur Heart J 2010;31(10):1257–1265. doi:10.1093/eurheartj/ehq021.
   PubMed Web of Science ®Google Scholar
• Baber U, Mehran R, Giustino G, Cohen DJ, Henry TD, Sartori S, Ariti C, Litherland C, Dangas G, Gibson CM, et al. Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk scores from Paris. J Am Coll Cardiol 2016;67(19):2224–2234. doi:10.1016/j.jacc.2016.02.064.
   PubMed Web of Science ®Google Scholar
• Costa F, van Klaveren D, James S, Heg D, Raber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet 2017;389(10073):1025–1034. doi:10.1016/S0140-6736(17)30397-5.
   PubMed Web of Science ®Google Scholar
• Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011;123(23):2736–2747. doi:10.1161/CIRCULATIONAHA.110.009449.
   PubMed Web of Science ®Google Scholar
• Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005;3(4):692–694. doi:10.1111/j.1538-7836.2005.01204.x.
   PubMed Web of Science ®Google Scholar
• Mega JL, Braunwald E, Mohanavelu S, Burton P, Poulter R, Misselwitz F, Hricak V, Barnathan ES, Bordes P, Witkowski A, et al. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. Lancet 2009;374(9683):29–38. doi:10.1016/S0140-6736(09)60738-8.
   PubMed Web of Science ®Google Scholar
• Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115(17):2344–2351. doi:10.1161/CIRCULATIONAHA.106.685313.
   PubMed Web of Science ®Google Scholar
• Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med 2008;3:17. doi:10.1186/1751-0473-3-17.
   PubMedGoogle Scholar
• Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, Goodman SG, Windecker S, Darius H, Li J, et al. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. New Engl J Med 2019;380(16):1509–1524. doi:10.1056/NEJMoa1817083.
   PubMed Web of Science ®Google Scholar
• Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, et al. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. New Engl J Med 2017;377(16):1513–1524. doi:10.1056/NEJMoa1708454.
   PubMed Web of Science ®Google Scholar
• Vranckx P, Valgimigli M, Eckardt L, Tijssen J, Lewalter T, Gargiulo G, Batushkin V, Campo G, Lysak Z, Vakaliuk I, et al. Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Lancet 2019;394(10206):1335–1343. doi:10.1016/S0140-6736(19)31872-0.
   PubMed Web of Science ®Google Scholar
• Gibson CM, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Birmingham M, Ianus J, Burton P, van Eickels M, et al. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. New Engl J Med 2016;375(25):2423–2434. doi:10.1056/NEJMoa1611594.
   PubMed Web of Science ®Google Scholar
• Kiviniemi T, Puurunen M, Schlitt A, Rubboli A, Karjalainen P, Vikman S, Niemela M, Lahtela H, Lip GY, Airaksinen KE. Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention. Am J Cardiol 2014;113(12):1995–2001. doi:10.1016/j.amjcard.2014.03.038.
   PubMed Web of Science ®Google Scholar
• Yoshida R, Ishii H, Morishima I, Tanaka A, Morita Y, Takagi K, Yoshioka N, Hirayama K, Iwakawa N, Tashiro H, et al. Performance of HAS-BLED, ORBIT, PRECISE-DAPT, and Paris risk score for predicting long-term bleeding events in patients taking an oral anticoagulant undergoing percutaneous coronary intervention. J Cardiol 2019;73(6):479–487. doi:10.1016/j.jjcc.2018.10.013.
   PubMed Web of Science ®Google Scholar
• Kim HK, Tantry US, Smith SC Jr., Jeong MH, Park SJ, Kim MH, Lim DS, Shin ES, Park DW, Huo Y, et al. The East Asian Paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease. Thromb Haemost 2021;121(4):422–432. doi:10.1055/s-0040-1718729.
   PubMedGoogle Scholar
• Huo Y, Jeong Y-H, Gong Y, Wang D, He B, Chen J, Fu G, Chen Y, Li J, Li Y, et al. 2018 update of expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Sci Bull 2019;64(2095–9273):166. doi:10.1016/j.scib.2018.12.020.
   PubMedGoogle Scholar
• Okumura K, Inoue H, Atarashi H, Yamashita T, Tomita H, Origasa H. Validation of CHA₂DS₂-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation: an analysis of the J-RHYTHM registry. Circ J 2014;78(7):1593–1599. doi:10.1253/circj.CJ-14-0144.
   PubMed Web of Science ®Google Scholar
• Song L, Guan C, Yan H, Qiao S, Wu Y, Yuan J, Dou K, Yang Y, Dangas G, Xu B. Validation of contemporary risk scores in predicting coronary thrombotic events and major bleeding in patients with acute coronary syndrome after drug-eluting stent implantations. Catheter Cardiovasc Interv 2018;91(S1):573–581.
   PubMedGoogle Scholar
• Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. New Engl J Med 2009;361(11):1045–1057. doi:10.1056/NEJMoa0904327.
   PubMed Web of Science ®Google Scholar
• Shen AY, Yao JF, Brar SS, Jorgensen MB, Chen W. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol 2007;50(4):309–315. doi:10.1016/j.jacc.2007.01.098.
   PubMed Web of Science ®Google Scholar
• Manzano-Fernández S, Pastor FJ, Marín F, Cambronero F, Caro C, Pascual-Figal DA, Garrido IP, Pinar E, Valdés M, Lip GYH. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. Chest 2008;134(3):559–567. doi:10.1378/chest.08-0350.
   PubMed Web of Science ®Google Scholar
• Wei L, Su E, Liu W, Xing W, Liu X, Zhang Y, Wang S, Cheng Q, Qi D, Gao C. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation. BMC Cardiovasc Disord 2020;20(1):323. doi:10.1186/s12872-020-01609-8.
   PubMedGoogle Scholar
• Yamamoto K, Shiomi H, Morimoto T, Natsuaki M, Takeji Y, Watanabe H, Yoshikawa Y, Matsumura-Nakano Y, Shizuta S, Tanabe K, et al. Effect of renal dysfunction on the risks for ischemic and bleeding events in patients with atrial fibrillation receiving percutaneous coronary Intervention. Am J Cardiol 2020;125(3):399–408. doi:10.1016/j.amjcard.2019.10.049.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Yamashita T, Hayakawa A, Matsumoto T, Takita A, Hasegawa C, Uchino K, Sekine T, Iizuka T, Tanabe H, et al. Bleeding risks associated with anticoagulant therapies after percutaneous coronary intervention in Japanese patients with ischemic heart disease complicated by atrial fibrillation: a comparative study. J Cardiol 2021;77(2):186–194. doi:10.1016/j.jjcc.2020.08.008.
   PubMed Web of Science ®Google Scholar
• Rocca B, Fox KAA, Ajjan RA, Andreotti F, Baigent C, Collet JP, Grove EL, Halvorsen S, Huber K, Morais J, et al. Antithrombotic therapy and body mass: an expert position paper of the ESC working group on thrombosis. Eur Heart J 2018;39(19):1672–1686f.
   PubMed Web of Science ®Google Scholar